Ovarian Cancer Awareness

Ovarian Cancer Research Fund is the oldest and largest charity in the country funding ovarian cancer research. Our mission is to fund sci... Read more

About

Ovarian Cancer Research Fund is the oldest and largest charity in the country funding ovarian cancer research. Our mission is to fund scientific research that leads to more effective identification, treatment, and ultimately a cure for ovarian cancer.

OCRF has invested over $50 million in ovarian cancer research through grants to scientists at 63 leading medical centers in the United States. Eighty-six percent (86%) of every dollar raised supports our programs.

For the third consecutive year, OCRF has achieved a prestigious 4-star rating from Charity Navigator, America’s premier independent charity evaluator, and ranks among the top 10% of all 4-star rated charities. Ovarian Cancer Research Fund is also a Better Business Bureau Accredited Charity that meets the BBB Wise Giving Alliance accreditation standards and has held their respected seal since 2010.

In an effort to raise ovarian cancer awareness and funds for research, OCRF offers lots of ways to educate people and support the cause. We produce and distribute brochures and fact sheets, offer free educational webinars, and provide research news, ovarian cancer facts and statistics through electronic and print newsletters, and on our website.

Our national gynecologic cancer patient support group, Woman to Woman, sponsored by QVC, provides trained and supervised volunteer survivors who give one -on–one emotional support and mentoring, as well as promote education and self advocacy for women in treatment, their partners, and families. This program is funded by grants from OCRF and is offered at select partner hospitals.

OCRF partners with corporations for exciting cause marketing campaigns and event sponsorships, providing the opportunity to make a difference by shopping, attending events, or hosting your own event.

For more information, please visit www.ocrf.org.

ABOUT OVARIAN CANCER

Cancer of the ovaries, the reproductive organs responsible for producing eggs and female hormones, is an insidious disease that can often strike without warning. Ovarian cancer is difficult to detect, as the symptoms of ovarian cancer are often vague and subtle, similar to those in other non cancer conditions affecting women. There is no effective screening test for ovarian cancer but tests exist that can identify women who are at higher risk for the disease.

STATISTICS

More than half of women who are diagnosed with ovarian cancer are 60 years or older.

American Cancer Society estimates 22,280 women will be diagnosed with ovarian cancer in the United States in 2012 and about 15,500 women will die from the disease.

Each year, 200,000 women are diagnosed worldwide with ovarian cancer, and 125,000 women die from this disease.

Overall, survival for women with ovarian cancer has been improving for the past 30 years.

SIGNS AND SYMPTOMS

There is no screening method for early detection for ovarian cancer. The symptoms of the disease are vague, and are not always gynecologic. But research shows that women with ovarian cancer often report having the following symptoms:

A swollen or bloated abdomen, increased girth. Some women notice that their pants or skirts are getting tight around the waist. The bloating is a sign that fluid, called ascites, is building up in the abdominal cavity in later stage disease;

Persistent pressure or pain in the abdomen or pelvis;

Difficulty eating or feeling full quickly;

Urinary concerns, such as urgency or frequency;

Change in bowel habits with new onset constipation and/or diarrhea;

Unexplained vaginal bleeding.

Any woman may have these symptoms for reasons not related to ovarian cancer. However, if these symptoms are new and unusual, and persist daily for more than two weeks, a woman should see her doctor, preferably a gynecologist, and should ask about ovarian cancer. For more information, click here.

GRADES

By looking at the cells in the tissue and fluid under a microscope, a pathologist describes the cancer as Grade 1, 2, or 3. Grade 1 is most like ovarian tissue and less likely to spread; Grade 3 cells are more irregular and more likely to metastasize. However, many ovarian cancers are categorized simply as “low grade” or “high grade.” Chemotherapy is often not used to treat low grade Stage I cases.

For more information about ovarian cancer, click here.

http://www.ocrf.org